Diabetes mellitus y obesidad: la importancia de realizar un abordaje integral de ambas entidades
DOI:
https://doi.org/10.32818/reccmi.a4s1a3Keywords:
diabetes mellitus type 2 , obesity, GLP-1 receptor agonists , SGLT2 inhibitorsAbstract
We present a 63-year-old woman diagnosed with type 2 diabetes mellitus in 2007 and grade III obesity, in addition to gonarthrosis and sequelae of a traffic accident. She was unable to perform physical exercise due to gonarthrosis and the aftermath of the traffic accident. Progressive treatment with oral antidiabetic agents did not achieve optimal glycemic control after several years of follow-up. Neither there was an improvement in obesity despite following several diets prescribed by specialists. We offered her therapy with insulin but the patient rejected it systematically. Finally, the use of combined treatment with agonists of the GLP-1 receptor and SGLT-2 inhibitors allowed to achieve an adequate glycemic control for the first time. In the subsequent controls, HbA1c values of less than 7% were reached, in addition to a significant reduction in body weight, with good tolerance and without adverse effects.
Downloads
Metrics
References
American Diabetes Association. Standards of medical care in diabetes - 2014. Diabetes Care. 2014 Jan;37 Suppl 1:S14-80. doi: https://doi.org/10.2337/dc14-S014.
Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M et al. American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012 Jun;35(6):1364-79. doi: https://doi.org/10.2337/dc12-0413. Epub 2012 Apr 19.
Abdul-Ghani MA, DeFronzo RA. Inhibition of renal glucose reabsorption: a novel strategy for achieving glucose control in type 2 diabetes mellitus. Endocr Pract. 2008 Sep;14(6):782-90.
Bennett WL, Maruthur NM, Singh S, Segal JB, Wilson LM, Chatterjee R et al. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med. 2011 May 3;154(9):602-13. doi: https://doi.org/10.7326/0003-4819-154-9-201105030-00336. Epub 2011 Mar 14.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Miguel Martín-Romero, Miriam Navarro-Rodríguez, José David Galián-Ramírez, Raquel Pérez-Luján, Antonia María Castillo-Navarro
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
